Navigation Links
Investigational Drug Effective in Treating Iron Deficiency in Chronic Kidney Disease Patients on Dialysis: Study
Date:11/9/2013

Atlanta, GA (PRWEB) November 09, 2013

Doctors at the North Shore-LIJ Health System on Saturday will present late-breaking data showing that an investigational drug Triferic is well tolerated and effective in treating iron deficiency in patients with chronic kidney disease undergoing dialysis. This data will be presented at the American Society of Nephrology’s Kidney Week 2013 in Atlanta, GA.

Chronic kidney disease (CKD) is the slow loss of kidney function over time. The main function of the kidneys is to remove wastes and excess water from the body. When chronic kidney failure reaches an advanced stage, dangerous levels of fluid, electrolytes and wastes can accumulate in the body, and a patient will need to undergo hemodialysis (dialysis) – a machine that filters wastes, salts and fluid from the blood. A common problem for patients on dialysis is iron deficiency. The body needs a certain amount of iron for overall good health and healthy blood cells, but excess iron gradually builds up in tissues and organs, eventually damaging them. Standard, current care for dialysis patients with iron deficiency is to intravenously inject 100 mg of iron into the bloodstream. But this method can result in oxidative stress and harm to people on dialysis.

Steven Fishbane, MD, and Azzour Hazzan, MD from the North Shore-LIJ Health System’s Division of Nephrology in New York, in collaboration with Ajay Singh, MD, associate professor at Harvard Medical School, conducted two Phase 3 trials, CRUISE-1 and CRUISE-2, which demonstrated, in 300 patients in each trial, that Triferic administered at each dialysis treatment for up to 48 weeks effectively delivers iron and maintains the body’s hemoglobin concentration constant. Triferic is a novel iron compound that has a unique mode of action in that it is delivered to the patient via their dialysis treatment as opposed to intravenous delivery. Triferic gradually delivers iron to the bone marrow and maintains hemoglobin without the rapid flux of iron caused by intravenous injection.

“Up until now, iron deficiency in chronic kidney disease patients who undergo dialysis has been treated almost exclusively with intravenous iron, which injects a large amount of iron directly into the blood stream. This can potentially be toxic for patients,” said Dr. Fishbane. “Our study is important and should be of interest to patients because it shows Triferic is effective in preventing iron deficiency without inducing iron overload in patients. It more closely mimics the slower natural way of absorbing iron and with additional studies, we might be able to show it is an improved and preferred treatment option.”

About North Shore-LIJ Health System

One of the nation's largest healthcare systems, North Shore-LIJ delivers world-class clinical care throughout the New York metropolitan area, pioneering research at The Feinstein Institute for Medical Research and a visionary approach to medical education highlighted by the Hofstra North Shore-LIJ School of Medicine. North Shore-LIJ cares for people at every stage of life at 16 hospitals and nearly 400 outpatient physician practices throughout the region. North Shore-LIJ’s owned hospitals and long-term care facilities house more than 6,000 beds, employ more than 10,000 nurses and have affiliations with more than 9,400 physicians. With a workforce of more than 46,000, North Shore-LIJ is the largest employer on Long Island and the third-largest private employer in New York City. For more information, go to http://www.northshorelij.com.

About American Society of Nephrology (ASN)

Founded in 1966, and with more than 14,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

ASN Kidney Week 2013, the largest nephrology meeting of its kind, will provide a forum for 14,000 professionals to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Kidney Week 2013 will take place November 5 – 10, 2013 in Atlanta, GA.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11314672.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH launches trial of investigational genital herpes vaccine
2. Investigational PARP inhibitor promising in BRCA-related cancers
3. Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
4. Investigational malaria vaccine found safe and protective
5. Method patent issued for investigational new class of pain medication
6. Investigational agent targets gene signaling pathways to improve response for patients with CLL
7. Mayo Clinic: Less-invasive option as effective as esophagus removal in early esophageal cancer
8. Cost-effective method accurately orders DNA sequencing along entire chromosomes
9. Marci Lock - a Leader in Effective Workout Systems - Offers New Packages That Offer Four Motivational Tools for the Price of One
10. Study looks at safety, effectiveness of generics for treating depression
11. Brock Educational Seminar Brings Experts in Injury Prevention, Sustainability and Landscape Design Together to Discuss Building Safer, More Eco-effective Playing Fields
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2019)... ... November 14, 2019 , ... EMulate ... other serious diseases, announced it will have 5 poster presentations related to its ... Annual Society for Neuro-Oncology SNO Meeting in Phoenix, beginning on November 20 . ...
(Date:11/14/2019)... ... November 14, 2019 , ... BioInformatics Inc., part of Science and ... today announced that 7 companies have been nominated for a Life Science Industry ... Since 2002, the Life Science Industry Awards have recognized manufacturers of the “tools of ...
(Date:11/14/2019)... ... 2019 , ... PMB-developed medical facilities have been honored as ... projects include an adaptive reuse movie theater project in Goodyear, Ariz. associated with ... medical care to an underserved community; and an urban high-rise ambulatory care center ...
(Date:11/14/2019)... ... November 14, 2019 , ... AstraZeneca and MSD (Merck) ... to file status of its application for the MEK inhibitor selumetinib, for use ... one (NF1). The FDA’s acceptance of the application is a major milestone for ...
(Date:11/14/2019)... ... ... around the corner, parents want to make sure their children are nice and cozy – ... during a car ride they can become dangerous, no matter how quick the journey. ... maximum safety during a crash or sudden stop. While children may want to be wrapped ...
Breaking Medicine News(10 mins):
(Date:11/14/2019)... , ... November 14, 2019 , ... ... natural foods distributor in the United States, UNFI. Starting January 2020, all five ... centers. , LivBars are a USDA Certified Organic hand-baked energy bar that has ...
(Date:11/14/2019)... (PRWEB) , ... November 14, 2019 , ... ... for clinical trials, announced today that it has reached a milestone in the ... in more than 200 regulatory submissions from biopharmaceutical clients for therapies and indications ...
(Date:11/14/2019)... Fla. (PRWEB) , ... November 14, 2019 , ... MaintenX ... and patient services in Tampa Bay at the 7th Annual Treasure Chests 5K and ... on by the Tampa Bay Buccaneers and powered by Jabil. , “We are ...
Breaking Medicine Technology: